Metoclopramide 5 mg
1 INDICATIONS AND USAGE Metoclopramide tablets are indicated for the: Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy. Relief of symptoms in adults with acute and recurrent diabetic gastroparesis. Limitations of Use : Metoclopramide tablets are not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates [ see Use in Specific Populations ( 8.4 ) ]. Metoclopramide tablets are indicated for the: Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy. ( 1 ) Relief of symptoms in adults with acute and recurrent diabetic gastroparesis. ( 1 ) Limitations of Use : Metoclopramide tablets are not recommended for use in pediatric patients due to the risk of tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates. ( 1 , 8.4 )
Teva Pharmaceuticals USA, Inc.
ROUND WHITE TV 2204
TV 2204 ROUND WHITE
Related Pills
Metoclopramide 10 mg
Teva Pharmaceuticals USA, Inc.
Metoclopramide 10 mg
Teva Pharmaceuticals USA, Inc.
Metoclopramide 5 mg
teva pharmaceuticals usa, inc.
metoclopramide 5 MG Oral Tablet
NuCare Pharmaceuticals, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Each white, round, unscored, debossed “TV” on one side and “2204” on the other side, compressed
METOCLOPRAMIDE tablet, USP contains
METOCLOPRAMIDE hydrochloride, USP equivalent to 5 mg
METOCLOPRAMIDE. Available in bottles of 100 (NDC 0093-2204-01) and 500 (NDC 0093-2204-05). Each white, round, scored, debossed “TEVA” on one side and “2203” above the score on the other side, compressed
METOCLOPRAMIDE tablet, USP contains
METOCLOPRAMIDE hydrochloride, USP equivalent to 10 mg
METOCLOPRAMIDE. Available in bottles of 100 (NDC 0093-2203-01), 500 (NDC 0093-2203-05), and 1,000 (NDC 0093-2203-10). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. PROTECT FROM LIGHT. This product is light sensitive. It should be inspected before use and discarded if either color or particulate is observed. Dispense in a tight, light-resistant container. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
More pills like ROUND TV 2204